BR0015489A - Preparação de uma lactona macrocìclica - Google Patents

Preparação de uma lactona macrocìclica

Info

Publication number
BR0015489A
BR0015489A BR0015489-0A BR0015489A BR0015489A BR 0015489 A BR0015489 A BR 0015489A BR 0015489 A BR0015489 A BR 0015489A BR 0015489 A BR0015489 A BR 0015489A
Authority
BR
Brazil
Prior art keywords
formula
compound
preparation
independently
double bond
Prior art date
Application number
BR0015489-0A
Other languages
English (en)
Other versions
BR0015489B1 (pt
Inventor
Johannes Paul Pachlatko
Thomas Pitterna
Volker Jungmann
Original Assignee
Syngenta Participations Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations Ag filed Critical Syngenta Participations Ag
Publication of BR0015489A publication Critical patent/BR0015489A/pt
Publication of BR0015489B1 publication Critical patent/BR0015489B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Patente de Invenção: "PREPARAçãO DE UMA LACTONA MACROCìCLICA". Objeto da invenção é um processo para a preparação de um composto da fórmula no qual R~ 1~ - R~ 9~ representam, independentemente um do outro hidrogênio ou um substituinte; m é 0, 1 ou 2; n é 0, 1, 2 ou 3; e as ligações marcadas com A, B, C, D, E e F indicam, independentemente uma da outra, que dois átomos de carbono adjacentes estão conectados por uma ligação dupla, uma ligação simples, uma ligação simples e uma ponte de epóxido, ou uma ligação dupla e uma ponte de metileno, incluindo, onde aplicável, um isómero E/Z, uma mistura de isómeros E/Z, e/ou um tautómero do mesmo, em cada caso em forma livre ou em forma de sal, qual processo compreende 1) formar ponte em um composto da fórmula onde R~ 1~ - R~ 7~, m, n, A, B, C, D, E e F têm os mesmos significados como dados para fórmula (1) acima, em contato com um biocatalisador que é capaz de especificamente oxidar o álcool na posição 4" a fim de formar um composto da fórmula no qual R~ 1~, R~ 2~,R~ 3~, R~ 4~, R~ 5~, R~ 6~,R~ 7~, m, n, A, B, C, D, E e F têm os significados dados para fórmula (I); e 2) reagir o composto da fórmula (III) com uma amina da fórmula HN(R~ 8~)R~ 9~, onde R~ 8~ e R~ 9~ têm os mesmos significados como dado para fórmula (I), e o qual é conhecido, na presença de um agente redutor.
BRPI0015489-0A 1999-11-12 2000-11-10 processos para preparação de uma lactona macrocìclica. BR0015489B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9926887.2A GB9926887D0 (en) 1999-11-12 1999-11-12 Organic compounds
GB9926887.2 1999-11-12
PCT/EP2000/011139 WO2001036434A1 (en) 1999-11-12 2000-11-10 Preparation of a macrocyclic lactone

Publications (2)

Publication Number Publication Date
BR0015489A true BR0015489A (pt) 2002-06-25
BR0015489B1 BR0015489B1 (pt) 2012-11-27

Family

ID=10864471

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0015489-0A BR0015489B1 (pt) 1999-11-12 2000-11-10 processos para preparação de uma lactona macrocìclica.

Country Status (24)

Country Link
US (1) US6808903B1 (pt)
EP (1) EP1228078B1 (pt)
JP (1) JP3671003B2 (pt)
KR (1) KR20020063890A (pt)
CN (2) CN100519574C (pt)
AR (1) AR026411A1 (pt)
AT (1) ATE240340T1 (pt)
AU (1) AU763109B2 (pt)
BR (1) BR0015489B1 (pt)
CA (1) CA2388824A1 (pt)
CZ (1) CZ20021616A3 (pt)
DE (1) DE60002751T2 (pt)
DK (1) DK1228078T3 (pt)
ES (1) ES2199883T3 (pt)
GB (1) GB9926887D0 (pt)
HK (1) HK1051204A1 (pt)
HU (1) HUP0204437A3 (pt)
IL (2) IL149369A0 (pt)
MX (1) MXPA02004512A (pt)
PL (1) PL354894A1 (pt)
PT (1) PT1228078E (pt)
RU (1) RU2234511C2 (pt)
WO (1) WO2001036434A1 (pt)
ZA (1) ZA200203612B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068788A1 (en) * 2001-05-16 2003-04-10 Buckel Thomas Gunther Methods and compositions for making emamectin
NZ548935A (en) * 2006-07-06 2007-03-30 Wyeth Corp Biocatalytic oxidation of LL-F28249-alpha
CN109485683A (zh) * 2018-11-27 2019-03-19 齐鲁晟华制药有限公司 一种含氟系列阿维菌素衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
US4874749A (en) * 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
US5030622A (en) * 1989-06-02 1991-07-09 Merck & Co., Inc. Avermectin derivatives
IL98599A (en) 1990-06-28 1995-06-29 Merck & Co Inc Stable salts of "4-deoxy-" 4-epi-methylamino abramectin and insecticides containing them
EP0736252A3 (en) * 1995-04-05 1997-05-02 Ciba Geigy Ag Synergistic compositions with diafanthiuron

Also Published As

Publication number Publication date
CN1390226A (zh) 2003-01-08
MXPA02004512A (es) 2002-09-02
CA2388824A1 (en) 2001-05-25
RU2002113754A (ru) 2004-01-20
ES2199883T3 (es) 2004-03-01
KR20020063890A (ko) 2002-08-05
IL149369A0 (en) 2002-11-10
PT1228078E (pt) 2003-09-30
RU2234511C2 (ru) 2004-08-20
CN100519574C (zh) 2009-07-29
CN1523116A (zh) 2004-08-25
CZ20021616A3 (cs) 2002-07-17
AR026411A1 (es) 2003-02-12
PL354894A1 (en) 2004-03-22
AU763109B2 (en) 2003-07-10
ATE240340T1 (de) 2003-05-15
IL149369A (en) 2007-07-04
JP2003514542A (ja) 2003-04-22
AU1520901A (en) 2001-05-30
CN1165542C (zh) 2004-09-08
EP1228078A1 (en) 2002-08-07
ZA200203612B (en) 2003-02-26
GB9926887D0 (en) 2000-01-12
DE60002751D1 (de) 2003-06-18
JP3671003B2 (ja) 2005-07-13
HUP0204437A2 (hu) 2003-04-28
EP1228078B1 (en) 2003-05-14
DK1228078T3 (da) 2003-09-15
WO2001036434A1 (en) 2001-05-25
HK1051204A1 (en) 2003-07-25
HUP0204437A3 (en) 2005-05-30
BR0015489B1 (pt) 2012-11-27
US6808903B1 (en) 2004-10-26
DE60002751T2 (de) 2004-02-26

Similar Documents

Publication Publication Date Title
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
BR0313723A (pt) Derivados de benzotiazol tendo atividade de agonista beta-2-adrenorreceptor
BR9911771A (pt) Compostos cìclicos substituìdos, um processo para sua preparação e composições farmacêuticas que contêm os mesmos
BRPI0609121B8 (pt) 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
BRPI0514644A (pt) composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna
BRPI0403234A (pt) Negro-de-fumo
BR0212695A (pt) Composto, composição artropodicida e método para o controle de artrópodes
BR0208396A (pt) Ureìa de éster vinìlico
BRPI0414514A (pt) uso de um composto, composto, e, composições farmacêuticas
BRPI0615111B8 (pt) composto, composição farmacêutica, e, uso do composto
BRPI0517423A (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
BRPI0509258A (pt) composto de 8-oxoadenina 9-substituìda
BR9913592A (pt) Compostos, processo de preparação dos compostos, e, composições farmacêuticas
BR0000666A (pt) Aminas impedidas por grupos n-alcóxi, substituìdas por hidróxi
BR0112093A (pt) Derivados de sulfonil-pirrolidina úteis no tratamento de distúrbios neurológicos
BRPI0406500A (pt) processo farmacêutico e compostos preparados pelo mesmo
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
BR0009389A (pt) Benzoilpirazóis substituìdos como herbicidas
BR0012478A (pt) Derivados de aminotiazóis, sua preparação e composição farmacêuticas contendo os mesmos
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
BR0308419A (pt) Derivados de azetidina como antagonistas do receptor ccr-3
BR0015489A (pt) Preparação de uma lactona macrocìclica
BRPI0411308A8 (pt) Composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BR0010225A (pt) Composto de amida, processo para prepará-lo, composição farmacêutica compreendendo dito composto, método de tratamento e uso

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/11/2012, MEDIANTE O RECOLHIMENTO DA TAXA QUINQUENAL DE MANUTENCAO (ARTIGOS 119 E 120 DA LPI) E OBSERVADAS AS DEMAIS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2386 DE 27-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.